← All indications
Hearing Loss, Noise-Induced
Hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.
Drugs by status
Phase 3 trials (1)
Phase 2 trials (11)
Phase 1 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (11)
- Bioelectron
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- University of Florida
- University of Michigan
- Sound Pharmaceuticals
- National Taiwan University
- Washington University in St. Louis
- Hearing Health Science, Inc.
- Municipal Hospital of Tainan, Taiwan
- Government of Taiwan
- Frequency Therapeutics
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (2)